What is the evidence supporting the use of cyclophosphamide in crescentic IgAN?
Year: 2026
Type: article
Abstract: No direct evidence for cyclophosphamide in crescentic IgAN was found, but its use is inferred from broader IgA nephropathy treatment guidelines and mixed-study results. It may be considered in practice, especially within a broader immunosuppressive strategy for severe cases.
Author: Tripdatabase
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7235356432
